Cholecystopancreatic disease
Conditions
Interventions
Experimental group:Clock Rotation catheterization
Control group:Conventional catheterization
Sponsors
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years and <= 70 years; 2.Voluntary and have signed the informed consent form for this clinical trial; 3.Clinically diagnosed with biliary or pancreatic diseases such as common bile duct stones, bile duct stenosis, acute biliary pancreatitis, etc., or requiring further diagnosis due to suspected biliary or pancreatic system diseases, and meeting the indications for ERCP; 4.Able to follow the 12-month visit plan and regularly return for follow-up according to the clinical trial research protocol; 5.Able to objectively describe symptoms and actively cooperate in completing the filling of relevant assessment scales; 6.No allergic diseases, no history of iodine contrast agent allergy; 7.Non-pregnant and non-pregnant women, and subjects who have no pregnancy plans within 3 months after the clinical trial; 8.Participated in this clinical trial within 3 months without participating in any other clinical trials; 9.If taking long-term anticoagulant drugs (such as aspirin, clopidogrel, warfarin, new oral anticoagulants, etc.), the drugs need to be discontinued for 5-7 days;
Exclusion criteria
Exclusion criteria: 1.Severe functional impairments of organs such as heart, brain, and lungs, making them unable to tolerate ERCP treatment; 2.Iodine contrast agent allergy; 3.Presence of coagulation dysfunction (INR > 1.3) and significant reduction in peripheral platelet count (< 50 × 10^9/L); 4.Complicated with severe liver diseases, intrahepatic bile duct stones, etc. 5.Having liver-biliary-pancreatic system tumors; 6.Having previously undergone ERCP; 7.Having undergone digestive tract reconstruction surgery; 8.Having other contraindications for ERCP examination and treatment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of catheterization; | — |
Secondary
| Measure | Time frame |
|---|---|
| Period of catheterization;The average length of stay;Pain symptom score of patients;The incidence of complications one week after the operation;Period of operation;X-ray exposure time; | — |
Countries
China
Contacts
Public ContactHu Ye
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Outcome results
None listed